PharmaCyte Biotech Ownership | Who Owns PharmaCyte Biotech?
PharmaCyte Biotech Ownership Summary
PharmaCyte Biotech is owned by 11.99% institutional investors, 8.89% insiders, and 79.12% retail investors. K2 principal fund is the largest institutional shareholder, holding 3.81% of PMCB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.53% of its assets in PharmaCyte Biotech shares.
PMCB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | PharmaCyte Biotech | 11.99% | 8.89% | 79.12% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 117.47K | 1.53% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 74.92K | 0.98% | - |
Fidelity Total Market Index | 55.70K | 0.73% | -10.22K |
Fidelity Extended Market Index | 43.32K | 0.56% | 4.45K |
Fidelity Nasdaq Composite Index | 26.21K | 0.34% | - |
Spartan Total Market Index Pool E | 19.64K | 0.26% | 161.00 |
Fidelity Series Total Market Index | 16.36K | 0.21% | -2.95K |
NT Ext Equity Mkt Idx Fd - NL | 14.43K | 0.19% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 11.63K | 0.15% | 36.00 |
Dimensional US Core Equity 2 ETF | 11.51K | 0.15% | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q4 | - | - |
2022 Q4 | - | - |
2022 Q3 | - | - |
2022 Q1 | - | - |
2021 Q3 | - | - |
PMCB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools